Survival in patients with intermediate or high grade non-Hodgkin's lymphoma: meta-analysis of randomized studies comparing third generation regimens with CHOP

por Messori, A, Vaiani, M, Trippoli, S, Rigacci, L, Jerkeman, M, Longo, G
Publicado 2001

Plasma immunoprofiling of patients with high-risk diffuse large B-cell lymphoma: a Nordic Lymphoma Group study

por Pauly, F, Fjordén, K, Leppä, S, Holte, H, Björkholm, M, Fluge, Ø, Møller Pedersen, L, Eriksson, M, Isinger-Ekstrand, A, Borrebaeck, C A K, Jerkeman, M, Wingren, C
Publicado 2016

P1264: HEMATOPOIETIC CLONES WITH TP53 MUTATIONS EXPAND IN PATIENTS WITH MCL DURING LENALIDOMIDE-BASED THERAPY

por Husby, S., Bæch-Laursen, C., Favero, F., Jespersen, J. S., Eskelund, C. W., Hutchings, M., Pedersen, L. B., Niemann, C. U., Weischenfeldt, J., Geisler, C., Räty, R., Larsen, T. S., Kolstad, A., Jerkeman, M., Grønbæk, K.
Publicado 2022

A platform for phenotypic discovery of therapeutic antibodies and targets applied on Chronic Lymphocytic Leukemia

por Ljungars, A., Mårtensson, L., Mattsson, J., Kovacek, M., Sundberg, A., Tornberg, U-C., Jansson, B., Persson, N., Emruli, V. Kuci, Ek, S., Jerkeman, M., Hansson, M., Juliusson, G., Ohlin, M., Frendéus, B., Teige, I., Mattsson, M.
Publicado 2018

Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study

por Rule, S, Jurczak, W, Jerkeman, M, Rusconi, C, Trneny, M, Offner, F, Caballero, D, Joao, C, Witzens-Harig, M, Hess, G, Bence-Bruckler, I, Cho, S-G, Thieblemont, C, Zhou, W, Henninger, T, Goldberg, J, Vermeulen, J, Dreyling, M
Publicado 2018